| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Verena Amberger-Murphy | |
| P433 | issue | 3 | |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | 381-390 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | Current Cancer Drug Targets | Q332547 |
| P1476 | title | Hypoxia helps glioma to fight therapy | |
| P478 | volume | 9 |
| Q38843065 | A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma |
| Q41650486 | A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET. |
| Q64912959 | Adaptive Changes of Glioblastoma Cells Following Exposure to Hypoxic (1% Oxygen) Tumour Microenvironment. |
| Q39568663 | Antiangiogenesis enhances intratumoral drug retention |
| Q37883011 | Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? |
| Q38754406 | Antidepressant drugs can modify cytotoxic action of temozolomide |
| Q36347256 | BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression |
| Q34050020 | Combined diffusion and perfusion MR imaging as biomarkers of prognosis in immunocompetent patients with primary central nervous system lymphoma |
| Q33802617 | Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials |
| Q64078835 | Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells |
| Q38842641 | Designing a Microfluidic Device with Integrated Ratiometric Oxygen Sensors for the Long-Term Control and Monitoring of Chronic and Cyclic Hypoxia |
| Q64102371 | Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies |
| Q33742292 | Di-ethylhexylphthalate (DEHP) modulates cell invasion, migration and anchorage independent growth through targeting S100P in LN-229 glioblastoma cells |
| Q39140400 | Endothelial differentiation of adipose tissue-derived mesenchymal stromal cells in glioma tumors: implications for cell-based therapy. |
| Q26781703 | Gamma-enolase: a well-known tumour marker, with a less-known role in cancer |
| Q33828114 | Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety. |
| Q35914515 | Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion |
| Q37807468 | Glioblastoma, cancer stem cells and hypoxia |
| Q92604874 | HIF-1α/Wnt signaling-dependent control of gene transcription regulates neuronal differentiation of glioblastoma stem cells |
| Q28478325 | Heterogeneous role of the glutathione antioxidant system in modulating the response of ESFT to fenretinide in normoxia and hypoxia |
| Q39319634 | Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide. |
| Q38782380 | Hypoxia Modulates the Swelling-Activated Cl Current in Human Glioblastoma Cells: Role in Volume Regulation and Cell Survival |
| Q38533276 | Hypoxia in astrocytic tumors and implications for therapy |
| Q39484769 | Hypoxia induces peroxisome proliferator-activated receptor α (PPARα) and lipid metabolism peroxisomal enzymes in human glioblastoma cells. |
| Q39340344 | Hypoxia modulation of peroxisome proliferator-activated receptors (PPARs) in human glioblastoma stem cells. Implications for therapy |
| Q36978100 | Identification of novel hypoxia response genes in human glioma cell line a172. |
| Q37702083 | In vivo radiation response of proneural glioma characterized by protective p53 transcriptional program and proneural-mesenchymal shift. |
| Q34988108 | Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells |
| Q39404395 | Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal-regulated kinase |
| Q50630850 | Isolation and expansion of regionally defined human glioblastoma cells in vitro. |
| Q48262720 | Leakage correction improves prognosis prediction of dynamic susceptibility contrast perfusion MRI in primary central nervous system lymphoma |
| Q55463274 | Matrix metalloproteinase 2 attenuates brain tumour growth, while promoting macrophage recruitment and vascular repair. |
| Q38997187 | Medical Imaging Informatics |
| Q38982185 | MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma |
| Q39403123 | Mislocalization of the exitatory amino-acid transporters (EAATs) in human astrocytoma and non-astrocytoma cancer cells: effect of the cell confluence |
| Q34029911 | Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide |
| Q64244722 | Nitric Oxide Antagonism to Anti-Glioblastoma Photodynamic Therapy: Mitigation by Inhibitors of Nitric Oxide Generation |
| Q36861550 | Oncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells |
| Q57042404 | Phenotypic and Expressional Heterogeneity in the Invasive Glioma Cells |
| Q30871297 | Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imagin |
| Q34130984 | Protein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxia |
| Q36906753 | Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth. |
| Q53286756 | Proteomic analysis of hypoxia-induced U373MG glioma secretome reveals novel hypoxia-dependent migration factors. |
| Q37688085 | Proton-beam therapy for tumors of the CNS. |
| Q41370914 | Reductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in Mice. |
| Q38587724 | Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma |
| Q38903930 | STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma. |
| Q27314916 | Short-Term Differentiation of Glioblastoma Stem Cells Induces Hypoxia Tolerance |
| Q35273402 | Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe |
| Q37664046 | Subcurative radiation significantly increases cell proliferation, invasion, and migration of primary glioblastoma multiforme in vivo |
| Q35759208 | Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment |
| Q34754083 | Temozolomide modifies caveolin-1 expression in experimental malignant gliomas in vitro and in vivo |
| Q64061395 | The Volume-Regulated Anion Channel in Glioblastoma |
| Q64028954 | The cellular effects of novel triazine nitrogen mustards in glioblastoma LBC3, LN-18 and LN-229 cell lines |
| Q41495146 | The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma. |
| Q35623519 | Tissue Reactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Tumors of Neuroectodermal, Mesodermal, and Epithelial Origin |
| Q42579310 | Transcription factor Sp1 induces ADAM17 and contributes to tumor cell invasiveness under hypoxia |
| Q28069398 | Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy |
| Q34394233 | mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy |
| Q37653216 | p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells |
Search more.